文献速递血管炎

血浆代谢相关蛋白与未来发生巨细胞动脉炎的关联:一项前瞻性研究结果

Associations between plasma metabolism-associated proteins and future development of giant cell arteritis: results from a prospective study.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在基于人群的马尔默饮食与癌症研究(MDCS,N=30447)中,95例后续确诊巨细胞动脉炎(GCA)者与匹配无GCA对照的基线血浆经OLINK代谢蛋白面板(92种蛋白)分析。ADGRE2每升高1个标准差与GCA正相关(OR 1.67;95%CI 1.08-2.57),FBP1每升高1个标准差与GCA负相关(OR 0.59;95%CI 0.35-0.99)。Metrnl在距诊断最近样本中风险影响最大且随时间延长呈递减趋势(P=0.03),假设生成分析中ROR1升高与后续GCA相关。

要点

  • ADGRE2每升高1个标准差与GCA风险正相关(OR 1.67;95%CI 1.08-2.57)。
  • FBP1每升高1个标准差与GCA风险负相关(OR 0.59;95%CI 0.35-0.99)。
  • Metrnl对GCA风险的影响在距诊断最近样本中最大,随时间延长呈递减趋势(P=0.03)。

核心结论

  • 临床诊断前数年识别的生物标志物提示糖异生(FBP1)的保护作用,以及巨噬细胞活化(ADGRE2和Metrnl)和促炎信号(ROR1)与GCA发生的关联。

研究设计与样本

  • 基于人群的马尔默饮食与癌症研究(MDCS;N=30447)中,以结构化流程识别后续确诊GCA者,并从研究队列选取匹配的无GCA对照。
  • 基线血浆样本使用基于抗体的OLINK蛋白质组学代谢面板(92种代谢蛋白)分析,分析预先指定为假设驱动或假设生成。
  • 假设生成分析中使用主成分分析识别解释蛋白质组变异的蛋白组。

主要发现

  • 共95例确诊为 incident GCA 的病例(纳入后中位12.0年)。
  • 在有先验假设的生物标志物中,ADGRE2每升高1个标准差与GCA正相关(OR 1.67;95%CI 1.08-2.57),FBP1每升高1个标准差与GCA负相关(OR 0.59;95%CI 0.35-0.99)。
  • ADGRE2水平与后续GCA的关联尤其见于诊断前<8.5年采样的子集。
  • Metrnl对GCA风险的影响在距诊断最近采样的患者中最大,随至GCA时间延长呈递减趋势(P=0.03)。
  • 在假设生成分析中,受体酪氨酸样孤儿受体1(ROR1)水平升高与后续GCA相关。

关键数值与推荐

  • ADGRE2每升高1个标准差与GCA的OR为1.67(95%CI 1.08-2.57)。
  • FBP1每升高1个标准差与GCA的OR为0.59(95%CI 0.35-0.99)。
  • Metrnl对GCA风险的影响随至诊断时间延长呈递减趋势(P=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the relationship between biomarkers associated with metabolism and subsequent development of GCA. METHOD: Participants in the population-based Malmö Diet Cancer Study (MDCS; N = 30 447) who were subsequently diagnosed with GCA were identified in a structured process. Matched GCA-free controls were selected from the study cohort. Baseline plasma samples were analysed using the antibody-based OLINK proteomics metabolism panel (92 metabolic proteins). Analyses were pre-designated as hypothesis-driven or hypothesis-generating. In the latter, principal component analysis was used to identify groups of proteins that explained the variance in the proteome. RESULTS: There were 95 cases with a confirmed incident diagnosis of GCA (median 12.0 years after inclusion). Among biomarkers with a priori hypotheses, adhesion G protein-coupled receptor E2 (ADGRE2) was positively associated [odds ratio (OR) per S.D. 1.67; 95% CI 1.08-2.57], and fructose-1,6-bisphosphatase 1 (FBP1) was negatively associated (OR per S.D. 0.59; 95% CI 0.35-0.99) with GCA. In particular, ADGRE2 levels were associated with subsequent GCA in the subset sampled <8.5 years before diagnosis. For meteorin-like protein (Metrnl), the highest impact on the risk of GCA was observed in those patients sampled closest to diagnosis, with a decreasing trend with longer time to GCA (P = 0.03). In the hypothesis-generating analyses, elevated levels of receptor tyrosine-like orphan receptor 1 (ROR1) were associated with subsequent GCA. CONCLUSION: Biomarkers identified years before clinical diagnosis indicated a protective role of gluconeogenesis (FBP1) and an association with macrophage activation (ADGRE2 and Metrnl) and proinflammatory signals (ROR1) for development of GCA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wadström K, Jacobsson LTH, Mohammad AJ, et al. Associations between plasma metabolism-associated proteins and future development of giant cell arteritis: results from a prospective study. Rheumatology (Oxford). 2025. PMID: 38310345. doi:10.1093/rheumatology/keae073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。